Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylbutyrate/Genistein Duotherapy in Cystic Fibrosis
NCT00590538Phase 2Terminated
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Feb 2003
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing Phenylbutyrate with Placebo (2 arms). Primary endpoint: Change in Voltage in Nasal Epithelium at 2 weeks. Started Feb 2003; status: terminated.
02
Drugs
sodium phenylbutyrate
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00590538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00590538.